PhytoMedical Expands Scope of Patented Technology That Kills Cancer Cells
December 31st, 2007
In response to the success of the studies, PhytoMedical‘s collaborating scientists are now synthesizing and testing new derivatives of these anti-cancer agents. Further tests of the “DNA binding“ anti-cancer agents are planned for human cancer cell lines specific to glioblastoma (tumors related to the brain) and small cell lung cancer, both of which are associated with a high mortality rate.
At 9:30 am on November 4th, 2008 Chuck Rogge said:
I don’t understand this web site? There seems to be all these “good posts” about small cell lung cancer like this one but there isn’t a way to read the full article or any way to get ahold of the researchers to get into a study.
At 2:19 pm on November 6th, 2008 Debi said:
Hello Chuck. To view the full article, please click on the link which is underlined and pink (or blue). Normally in most articles, they usually don’t include contact numbers for the people they are writing about but we’re happy to try and help.